Therapies in Disorders of Lipid Metabolism and Obesity
Akuffo Quarde MD2023Other
Endocrine (ADH/ACTH/MSH)
Abstract
This chapter delves into the pathophysiology of hyperlipidemia, obesity, and lipodystrophy syndromes. The rationale for using selected therapies in these conditions is presented after reviewing relevant concepts in endocrine physiology. Where relevant, selected clinical trial data is reviewed.
Part of CIRS Nexus · Curated by Lauren Lowenstein, The Biotoxin Lady
Related Papers
- Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177Frontiers in Immunology · 2022 · 1 shared tag
- Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular ModelsFrontiers in Neuroscience · 2021 · 1 shared tag
- CGRP sensory neurons promote tissue healing via neutrophils and macrophagesNature · 2024 · 1 shared tag
- Invited review: Mechanisms of hypophagia during diseaseJournal of Dairy Science · 2021 · 1 shared tag
- Considering traditional Chinese medicine as adjunct therapy in the management of chronic constipation by regulating intestinal floraBioScience Trends · 2024 · 1 shared tag
- Lipid-Induced Insulin Resistance Mechanisms: The Link to Inflammation and Type 2 Diabetes.2021 · 1 shared tag